Search

637 results
Home > GMO dealings > Dealings involving intentional release

Clinical trial of live attenuated genetically modified influenza vaccines

Home > GMO dealings > Dealings involving intentional release

Commercial release of cotton genetically modified for insect resistance and herbicide tolerance (GlyTol® (BCS-GH002-5) and GlyTol TwinLink Plus® (BCS-GH002-5 x BCS-GH004-7 x BCS-GH005-8 x SYN-IR102-7)

Home > GMO dealings > Dealings involving intentional release

Limited and controlled release of wheat genetically modified for enhanced nitrogen use efficiency and water use efficiency - Victorian Department of Economic Development, Jobs, Transport and Resources (DEDJTR)

Home > GMO dealings
Home > GMO dealings > Dealings involving intentional release

Clinical trial of a genetically modified virus for treatment of liver, kidney and prostate cancer

Home > About OGTR

If you have a question or would like to give us feedback, you can get in touch with us by email, phone, mail or online form. You can also subscribe to updates.

Home > GMO dealings > Dealings involving intentional release

Commercial import and distribution of chrysanthemum genetically modified for altered flower colour

Home > Resources > Publications

This issue provides an update on the OGTR office.

Home > Resources > Publications

Details of OGTR monitoring and compliance activities during the quarter ended 31 December 2021

Home > GMO dealings > Dealings involving intentional release

Clinical trial of a genetically modified (GM) chimeric Orthopoxvirus (CF33-hNIS) as a cancer treatment